Tianjin Ringpu Bio-technology Hits Day High with 5.71% Surge

Tianjin Ringpu Bio-technology Co., Ltd. has experienced a notable increase of 5.71% on March 6, 2026, reaching an intraday high of CNY 19.48. This performance stands out against the backdrop of the China Shanghai Composite, which saw a modest gain of 0.38% on the same day. Despite this positive movement, the company's performance over the past week has shown a decline of 2.18%, while its monthly performance remains slightly positive at 0.42%. Over the past year, Tianjin Ringpu has generated a return of 15.19%, although profits have decreased by 4.4%. The company operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 6,171 million. Key financial metrics include a price-to-earnings ratio of 23.00 and a return on equity of 9.66%. The stock also boasts a dividend yield of 2.28%, indicating a commitment to returning value to shareholders. As part of the Reliable Performers category on MarketsMOJO since September 2025, Tianjin Ringpu continues to navigate a competitive landscape while maintaining a fair valuation with a price-to-book ratio of 1.32.